Labcorp features a full-service offering to support physicians in the evaluation of patients for rheumatic diseases.
Tests to aid in the diagnosis, management of treatment, and monitoring of disease activity.
Therapeutic Drug Monitoring
Therapeutic drug monitoring tests help to optimize treatment of rheumatic disease.
Vectra by Labcorp
Vectra is an advanced blood test that objectively measures inflammation caused by rheumatoid arthritis.
Vectra With CV Risk
Vectra Cardiovascular Risk provides a personalized assessment of inflammation for patients with rheumatoid arthritis to predict their risk of a cardiovascular event in the next 3 years.
Comprehensive, innovative panels to help identify inflammatory myopathies.
Innovative autoimmune testing services to aid with the diagnosis, treatment, and management of complex autoimmune syndromes.
|504550||14.3.3 eta, Rheumatoid Arthritis|
|520311||Anti-Carbamylated Protein (CarP) Antibody|
|164914||Anti-CCP (Cyclic Citrullinated Peptide) Antibodies, IgG and IgA, ELISA|
|520133||Anti-CEP-1 Ab, IgG (RDL)|
|520081||Anti-Sa Ab, IgG (RDL)|
|504814||Hydroxychloroquine, Whole Blood|
|520091||RAdx5 Profile (RDL)|
|006502||Rheumatoid Factor (RF)|
|520209||SeroNeg RAdx3 Profile (RDL)|
|510750||Thiopurine Methyltransferase (TPMT), Enzyme Activity, Erythrocytes|
|504980||Vectra® with CV Risk|
|503890||Adalimumab and Anti-Adalimumab Antibody, DoseASSURE™ ADL|
|504627||Certolizumab and Anti-Certolizumab Antibody, DoseASSURE™ CTZ|
|504245||Etanercept and Anti-Etanercept Antibody, DoseASSURE™ ETN|
|504563||Golimumab and Anti-Golimumab Antibody, DoseASSURE™ GOL|
|503870||Infliximab and Anti-Infliximab Antibody, DoseASSURE™ IFX|
|504355||Rituximab and Anti-Rituximab Antibody, DoseASSURE™ RTX|
|504594||Ustekinumab and Anti-Ustekinumab Antibody, DoseASSURE™ UST|
|144441||Pre-Biologic Screening Profile|